CORTICOSTEROIDS AS ADJUNCTIVE THERAPY FOR DIFFUSE ALVEOLAR HEMORRHAGE ASSOCIATED WITH BONE-MARROW TRANSPLANTATION

被引:84
作者
METCALF, JP
RENNARD, SI
REED, EC
HAIRE, WD
SISSON, JH
WALTER, T
ROBBINS, RA
ARMITAGE, JO
ARNESON, M
BIERMAN, PJ
CURSEEN, AF
DARRINGTON, D
DICKE, KA
HUERTA, G
JONES, K
KESSINGER, A
RICKARD, KA
ROMBERGER, DJ
RUBENSTEIN, I
SHUMWAY, M
SPURZEM, JR
THOMPSON, AB
VAUGHAN, WP
VONESSEN, SG
VOSE, JM
YATES, RS
机构
[1] UNIV NEBRASKA, MED CTR, DEPT INTERNAL MED, PULM & CRIT CARE MED SECT, OMAHA, NE 68198 USA
[2] UNIV NEBRASKA, MED CTR, DEPT INTERNAL MED, HEMATOL ONCOL SECT, OMAHA, NE USA
[3] VET ADM MED CTR, RES SERV, OMAHA, NE USA
关键词
D O I
10.1016/0002-9343(94)90062-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Diffuse alveolar hemorrhage is a frequent complication of treating malignancies with high-dose chemotherapy and bone marrow transplantation and is associated with very high mortality. This disorder's association with pulmonary inflammation, its coincidence with marrow recovery, and the usefulness of corticosteroids for treating other pulmonary hemorrhage syndromes provided the rationale for this study. Methods: We retrospectively studied 65 episodes of diffuse alveolar hemorrhage that had occurred in 63 of 603 consecutively treated patients who had undergone high-dose chemotherapy with bone marrow transplantation. Patients were divided into three groups according to the therapy they had received for diffuse alveolar hemorrhage: supportive therapy alone in = 12); low-dose corticosteroids (30 mg or less of methylprednisolone or its equivalent; n = 10); and high-dose corticosteroids (more than 30 mg methylprednisolone or its equivalent; n = 43). The primary outcome measures were overall survival and survival to hospital discharge, occurrence of respiratory failure requiring intubation, and development of infections subsequent to the diagnosis of diffuse alveolar hemorrhage. Results: Overall survival at the end of the followup period was significantly higher for the high-dose corticosteroid group compared with the supportive therapy group (P = 0.005); however, treatment with low-dose steroids did not increase survival over supportive therapy alone (P = 0.198). In addition, survival to discharge was significantly increased for the high-dose group compared with the other two groups combined (33% versus 9.1%, P = 0.038). Respiratory failure after the diagnosis of diffuse alveolar hemorrhage developed in only 12 of the 22 unintubated patients in the high-dose group compared with 9 of the 10 initially unintubated patients in the other two groups (P = 0.056). Although the incidence of infections was high (40%) subsequent to diffuse alveolar hemorrhage, neither high-dose nor low-dose corticosteroid treatment significantly increased the risk of infections (P >0.4, all comparisons). Conclusions: In this study, high-dose corticosteroid therapy for diffuse alveolar hemorrhage related to bone marrow transplantation was associated with improved total survival and survival to hospital discharge, and decreased development of respiratory failure in these patients. These results suggest the therapy is beneficial, and further prospective studies are warranted to verify the effectiveness of the treatment.
引用
收藏
页码:327 / 334
页数:8
相关论文
共 39 条
[1]  
AHMED T, 1989, LEUKEMIA, V3, P19
[2]  
ARMITAGE JO, 1986, LANCET, V2, P960
[3]   ANTI-GLOMERULAR BASEMENT-MEMBRANE ANTIBODY-MEDIATED GLOMERULONEPHRITIS AND GOODPASTURES-SYNDROME [J].
BRIGGS, WA ;
JOHNSON, JP ;
TEICHMAN, S ;
YEAGER, HC ;
WILSON, CB .
MEDICINE, 1979, 58 (05) :348-361
[4]  
CHAN CK, 1990, CLIN CHEST MED, V11, P323
[5]   CORTICOSTEROID-THERAPY FOR DIFFUSE ALVEOLAR HEMORRHAGE IN AUTOLOGOUS BONE-MARROW TRANSPLANT RECIPIENTS [J].
CHAO, NJ ;
DUNCAN, SR ;
LONG, GD ;
HORNING, SJ ;
BLUME, KG .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (02) :145-146
[6]  
COOPER JAD, 1986, AM REV RESPIR DIS, V133, P321
[7]  
CORDONNIER C, 1986, CANCER, V58, P1047, DOI 10.1002/1097-0142(19860901)58:5<1047::AID-CNCR2820580512>3.0.CO
[8]  
2-Y
[9]   OPEN LUNG-BIOPSY DIAGNOSIS OF DIFFUSE PULMONARY-INFILTRATES AFTER MARROW TRANSPLANTATION [J].
CRAWFORD, SW ;
HACKMAN, RC ;
CLARK, JG .
CHEST, 1988, 94 (05) :949-953
[10]  
DINSMORE R, 1984, BLOOD, V63, P649